Advances in Cancer Immunotherapy™: A Focus on Hematologic Malignancies

When: Feb 2, 2022 from 16:00 to 20:00 (PT)

This program will be hosted virtually.

Organizers:
Samantha Shenoy, NP – UCSF Medical Center
Nina Shah, MD – University of California San Francisco
Charalambos Andreadis, MD, MSCE – University of California San Francisco

Program Learning Objectives

Identify the cancer immunotherapy approaches in use for the treatment of hematologic malignancies.
Summarize recent updates in cancer immunotherapy for hematologic malignancies and toxicity management for key disease states.
Implement cancer immunotherapy for hematologic malignancies into clinical practice appropriately.

For more information on the program, click below.

PROGRAM INFORMATION

View the SITC Meeting Code of Conduct.